{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:51:50Z","timestamp":1791193910150,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To investigate the effects of glycyrrhizic acid on HepG2 cell viability and the cellular uptake, retention, and washout kinetics of technetium-99m methoxyisobutylisonitrile (\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MIBI), with particular emphasis on the potential involvement of mitochondrial function and P-glycoprotein (P-gp)-mediated efflux.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      HepG2 cells were treated with glycyrrhizic acid at concentrations ranging from 0 to 100 \u03bcM, and cell viability was assessed using the MTT assay. Cellular\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MIBI uptake was evaluated over 5\u2013120\u2009min to characterize time-dependent tracer accumulation. Pulse-chase experiments were performed to assess intracellular tracer retention and washout over 30\u2013180\u2009min following tracer loading. The contribution of P-gp-mediated efflux was further investigated by assessing the effect of the P-gp inhibitor verapamil on intracellular\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MIBI accumulation in glycyrrhizic acid-treated cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Glycyrrhizic acid reduced HepG2 cell viability in a concentration- and time-dependent manner, with an IC\n                      <jats:sub>50<\/jats:sub>\n                      of approximately 60 \u03bcM after 48\u2009h. In untreated cells,\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MIBI accumulation progressively increased and approached a plateau between 60 and 120\u2009min. Glycyrrhizic acid treatment reduced intracellular tracer uptake in a concentration-dependent manner. Pulse-chase experiments demonstrated decreased intracellular tracer retention and increased washout following glycyrrhizic acid treatment. Pretreatment with verapamil partially increased intracellular\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MIBI accumulation compared with glycyrrhizic acid treatment alone, indicating that P-gp-mediated efflux may contribute to the reduced tracer retention observed after glycyrrhizic acid exposure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Glycyrrhizic acid alters\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MIBI uptake, intracellular retention, and washout kinetics in HepG2 cells. The observed changes are consistent with altered mitochondrial tracer sequestration and increased transporter-mediated efflux, although the present findings do not establish these mechanisms directly. Dynamic\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MIBI kinetics may therefore provide a functional approach for assessing cellular responses to glycyrrhizic acid, warranting further mechanistic and in-vivo validation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002249","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:00:09Z","timestamp":1791190809000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic 99mTc-MIBI uptake and washout as functional biomarkers of glycyrrhizic acid-induced mitochondrial dysfunction and P-glycoprotein activity in HepG2 cells"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-6261","authenticated-orcid":false,"given":"Fatma J.","family":"Al-Saeedi","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah Y.","family":"Sohrabi","sequence":"additional","affiliation":[{"name":"College of Medicine, Kuwait University, Sabah Al Salem University City, Shadadiya, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana A.","family":"Aryan","sequence":"additional","affiliation":[{"name":"College of Medicine, Kuwait University, Sabah Al Salem University City, Shadadiya, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema F.","family":"Marafi","sequence":"additional","affiliation":[{"name":"College of Medicine, Kuwait University, Sabah Al Salem University City, Shadadiya, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef A.","family":"Al-Fadhli","sequence":"additional","affiliation":[{"name":"College of Medicine, Kuwait University, Sabah Al Salem University City, Shadadiya, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaziz A.","family":"Saber","sequence":"additional","affiliation":[{"name":"College of Medicine, Kuwait University, Sabah Al Salem University City, Shadadiya, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal A.","family":"Esbita","sequence":"additional","affiliation":[{"name":"College of Medicine, Kuwait University, Sabah Al Salem University City, Shadadiya, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"R1-20261005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.17998\/jlc.2025.07.25","article-title":"Public health strategies for hepatocellular carcinoma: from risk factors to prevention and control.","volume":"25","author":"Lee","year":"2025","journal-title":"J Liver Cancer"},{"key":"R2-20261005","doi-asserted-by":"crossref","DOI":"10.1007\/s11523-026-01239-8","article-title":"Changing treatment landscape of hepatocellular carcinoma: a real-world retrospective analysis of treatment algorithms and outcomes of patients over 10 years.","author":"Bathon","year":"2026","journal-title":"Target Oncol"},{"key":"R3-20261005","doi-asserted-by":"crossref","first-page":"1854700","DOI":"10.3389\/fphar.2026.1854700","article-title":"Toward oral nanomaterial-based drug delivery systems for hepatocellular carcinoma therapy: evidence mapping, route-specific validation, and translational challenges.","volume":"17","author":"Fu","year":"2026","journal-title":"Front Pharmacol"},{"key":"R4-20261005","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1002\/tox.24295","article-title":"Glycyrrhizic acid attenuates the malignant biological properties of nonalcoholic fatty liver disease-related hepatocellular carcinoma.","volume":"39","author":"Huang","year":"2024","journal-title":"Environ Toxicol"},{"key":"R5-20261005","doi-asserted-by":"crossref","first-page":"105687","DOI":"10.1016\/j.tiv.2023.105687","article-title":"Glycyrrhizic acid enhances the anticancer activity of cisplatin in the human ovarian cancer cell line.","volume":"93","author":"Omidi","year":"2023","journal-title":"Toxicol In Vitro"},{"key":"R6-20261005","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2174\/1389557519666190119111125","article-title":"Research progress of glycyrrhizic acid on antiviral activity.","volume":"19","author":"Sun","year":"2019","journal-title":"Mini Rev Med Chem"},{"key":"R7-20261005","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/jpm13121639","article-title":"Glycyrrhizinic acid as an antiviral and anticancer agent in the treatment of human papillomavirus.","volume":"13","author":"Bravo","year":"2023","journal-title":"J Pers Med"},{"key":"R8-20261005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/S15327914nc391_1","article-title":"Licorice and cancer.","volume":"39","author":"Wang","year":"2001","journal-title":"Nutr Cancer"},{"key":"R9-20261005","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1440-1746.1999.02008.x","article-title":"Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I\/II trial.","volume":"14","author":"van Rossum","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"R10-20261005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0166-3542(88)90047-2","article-title":"Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV).","volume":"10","author":"Ito","year":"1988","journal-title":"Antiviral Res"},{"key":"R11-20261005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/ijnm.ijnm_91_22","article-title":"A prospective comparative study between 99mTc MIBI myocardial perfusion single-photon emission computed tomography and dobutamine stress echocardiography to detect viable myocardium in patients with coronary artery disease.","volume":"38","author":"Jha","year":"2023","journal-title":"Indian J Nucl Med"},{"key":"R12-20261005","first-page":"663","article-title":"Utility of (99m)Tc-Sestamibi Heart\/Liver uptake ratio in screening nonalcoholic fatty liver disease during myocardial perfusion imaging.","volume":"38","author":"Norouzi","year":"2023","journal-title":"Cancer Biother Radiopharm"},{"key":"R13-20261005","first-page":"1179","article-title":"Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.","volume":"39","author":"Taki","year":"1998","journal-title":"J Nucl Med"},{"key":"R14-20261005","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejps.2010.09.009","article-title":"Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.","volume":"41","author":"Krasznai","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"R15-20261005","first-page":"501","article-title":"Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.","volume":"38","author":"Taki","year":"1997","journal-title":"J Nucl Med"},{"key":"R16-20261005","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.31557\/APJCP.2024.25.9.3125","article-title":"In vivo detection of multidrug-resistance-related proteins in locally advanced breast cancer using 99mTc-MIBI SPECT\/CT imaging: correlation with clinical outcomes.","volume":"25","author":"Mostafa","year":"2024","journal-title":"Asian Pac J Cancer Prev"},{"key":"R17-20261005","first-page":"4171","article-title":"Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: application for early detection and follow-up of MDR phenotype.","volume":"27","author":"Dutour","year":"2007","journal-title":"Anticancer Res"},{"key":"R18-20261005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1142\/S0192415X20500123","article-title":"Glycyrrhizic acid modulates apoptosis through extrinsic\/intrinsic pathways and inhibits protein kinase B- and extracellular signal-regulated kinase-mediated metastatic potential in hepatocellular carcinoma in vitro and in vivo.","volume":"48","author":"Tsai","year":"2020","journal-title":"Am J Chin Med"},{"key":"R19-20261005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1211\/jpp.60.5.0013","article-title":"Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells.","volume":"60","author":"Hawthorne","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"R20-20261005","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/tox.22635","article-title":"Glycyrrhizic acid suppresses 1,2-dimethylhydrazine-induced colon tumorigenesis in Wistar rats: alleviation of inflammatory, proliferation, angiogenic, and apoptotic markers.","volume":"33","author":"Khan","year":"2018","journal-title":"Environ Toxicol"},{"key":"R21-20261005","first-page":"233","article-title":"Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells.","volume":"16","author":"Hibasami","year":"2005","journal-title":"Int J Mol Med"},{"key":"R22-20261005","first-page":"188","article-title":"Naturally occurring glycyrrhizin triterpene exerts anticancer effects on colorectal cancer cells via induction of apoptosis and autophagy and suppression of cell migration and invasion by targeting MMP-9 and MMP-2 expression.","volume":"25","author":"Zhang","year":"2020","journal-title":"J BUON"},{"key":"R23-20261005","first-page":"335","article-title":"Glycyrrhizic acid exerts protective effects against hypoxia\/reoxygenation-induced human coronary artery endothelial cell damage by regulating mitochondria.","volume":"20","author":"Tang","year":"2020","journal-title":"Exp Ther Med"},{"key":"R24-20261005","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.3390\/ijms20174134","article-title":"Antifibrotic effects of high-mobility group box 1 protein inhibitor (glycyrrhizin) on keloid fibroblasts and keloid spheroids through reduction of autophagy and induction of apoptosis.","volume":"20","author":"Jeon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R25-20261005","doi-asserted-by":"crossref","first-page":"152117","DOI":"10.1016\/j.ijbiomac.2026.152117","article-title":"Engineering of glycyrrhizin-loaded chitosan nanogel for pulmonary immunomodulation via regulation of NF-\u03baB signaling and macrophage polarization in lung inflammation.","volume":"362","author":"Liu","year":"2026","journal-title":"Int J Biol Macromol"},{"key":"R26-20261005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.31083\/ph.2025.5532","article-title":"Glycyrrhizic acid inhibited inflammatory response in LPS-stimulated microglial BV2 cells via MAPK, Akt, and NF-\u03baB signaling pathways.","volume":"80","author":"Cheng","year":"2025","journal-title":"Pharmazie"},{"key":"R27-20261005","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/00365521.2024.2315317","article-title":"Glycyrrhizic acid attenuates sorafenib resistance by inducing ferroptosis via targeting mTOR signaling in hepatocellular carcinoma.","volume":"59","author":"Hu","year":"2024","journal-title":"Scand J Gastroenterol"},{"key":"R28-20261005","doi-asserted-by":"crossref","first-page":"e945444","DOI":"10.12659\/MSM.945444","article-title":"Enhanced differentiation of amiodarone-induced thyrotoxicosis types using semi-quantitative 99mTc-MIBI uptake analysis: a pilot study.","volume":"30","author":"Fischer","year":"2024","journal-title":"Med Sci Monit"},{"key":"R30-20261005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clpt.2004.09.002","article-title":"Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.","volume":"77","author":"Wong","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"R31-20261005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1120-1797(06)80019-0","article-title":"Functional imaging of multidrug resistance in breast cancer.","volume":"21","author":"Vecchio","year":"2006","journal-title":"Phys Med"},{"key":"R32-20261005","doi-asserted-by":"crossref","first-page":"e0228848","DOI":"10.1371\/journal.pone.0228848","article-title":"99mTc-MIBI uptake as a marker of mitochondrial membrane potential in cancer cells and effects of MDR1 and verapamil.","volume":"15","author":"Park","year":"2020","journal-title":"PLoS One"},{"key":"R33-20261005","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1139\/y04-113","article-title":"Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562\/adr cells.","volume":"82","author":"Kothan","year":"2004","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:00:14Z","timestamp":1791190814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002249","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"2026-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}